Costa et al., Ophthalmic Surgery, vol. 24, No. 3, pp. 152-170, 1993.* |
Annen et al., “Follow Up of a Pilot Study of Trabeculectomy with Low Dosage Mitomycin C (0.2 mg/ml for 1 minute). Independent Evaluation of a Retrospective Non randomized Study,” Klin. Monatsbl Augenheilkd 206:300-302 (1995). |
Becker et al., “Comparison of Antibiotic Release from Polymethylmethacrylate Beads and Sponge Collagen,” J. Orthop Res. 12:737-741 (1994). |
Belyea et al., “Midterm Follow-Up Results of Combined Phacoemulsification, Lens Implantation, and Mitomycin-C Trabeculectomy Procedure,” J. Glaucoma 6:90-98 (1997). |
Bentz et al., “Improved Local Delivery of TGF-β-2 by Binding to Injectable Fibrillar Collagen Via Difunctional Polyethylene Glycol,” J. Biomed. Mater. Res. 39:539-548 (1998). |
Bloomfield et al., “Soluble Gentamicin Ophthalmic Inserts as a Drug Delivery System,” Arch. Ophthalmol 96:885-887 (1978). |
Boyce et al., “Attachment of an Aminoglycoside, Amikacin, to Implantable Collage for Local Delivery in Wounds,” Antimicrob Agents Chemotherapy 37:1890-1895 (1993). |
Bradley et al., “Some Mechanical Property Consideration of Reconstituted Collagen for Drug Release Supports,” Biomater. Med. Devices Artif. Organs 5:159-175 (1977). |
Campagna et al., “Tenon's Cyst Formation After Trabeculectomy with Mitomycin,” Ophthalmic Surg. 26:57-60 (1995). |
Cascone et al., “Blends of Synthetic and Natural Polymers as Drug Delivery Systems for Growth Hormone,” Biomaterials 16:569-574 (1995). |
Costa et al., “Wound Healing Modulation in Glaucoma Filtration Surgery,” Ophthalmic Surg. 24:152-170 (1993). |
Davidson et al., “Collagen Matrix Cisplatin Prevents Local Tumor Growth After Margin-Positive Resection,” J. Surg. Res. 58:618-624 (1995). |
Devore et al., “Delivery of Mitomycin C Using Rapidly Dissolving Films,” IOVS 39: (1998). |
Dorr et al., “In Vitro Retinoid Binding and Release from a Collagen Sponge Material in a Simulated Intravaginal Environment,” J. Biomed. Mater. Res. 16:839-850 (1982). |
Friess, “Collagen-Biomaterial for Drug Delivery,” Eur. J. Pharm. Biopharm. 45:113-136 (1998). |
Friess et al., “Insoluble Collagen Matrices for Prolonged Delivery of Proteins,” Pharm. Dev. Technol. 1:185-193 (1996). |
Gebhardt et al., “Cyclosporine in Collage Particles: Corneal Penetration and Suppression of Allograft Rejection,” J. Ocul. Pharm. Ther. 11:509-517 (1995). |
Gebhardt et al., “Collagen as a Delivery System for Hydrophobic Drugs: Studies with Cyclosporine,” J. Ocul. Pharmacol. Ther. 11:319-327 (1995). |
Greenfield et al., “Late-Onset Bleb Leaks After Glaucoma Filtering Surgery,” Arch. Ophthalmol 116:443-447 (1998). |
Hakim et al., “Use of Biodegradable Mesh as a Transport for a Cultured Uroepithelial Graft: An Improved Method Using Collagen Gel,” Urology 44:139-142 (1994). |
Hall et al., “Targeting Retroviral Vectors to Vascular Lesions by Genetic Engineering of the McMLV gp70 Envelope Protein,” Hum. Gene. Ther. 10:2183-2192 (1997). |
Hasty et al., “Primate Trabeculectomies with 5-Fluorouracil Collagen Implants,” American Journal of Ophthalmology 109:721-725 (1990). |
Herschler et al., “Long-Term Results of Trabeculectomy with Collagen Sponge Implant Containing Low-Dose Antimetabolite,” Ophthalmology 99:666-670 (1992). |
Inoue et al., “Effect of Collagen Matrix Containing Epidermal Growth Factor on Wound Contradiction,” Wound Repair Regen. 6:213-222 (1998). |
Kay et al., “Delivery of Antifibroblast Agents as Adjuncts to Filtration Surgery. Part I—Periocular Clearance of Cobalt-57 Bleomycin in Experimental Drug Delivery: Pilot Study in the Rabbit,” Ophthalmic Surg. 17:626-630 (1986). |
Kay et al., “Delivery of Antifibroblast Agents as Adjuncts to Filtration Surgry—Part II: Delivery of 5-Fluorouracil and Bleomycin in a Collagen Implant: Pilot Study in the Rabbit,” Ophthalmic Surgery 17:796-801 (1986). |
Keiji et al., “Method for Producing a Sustained Release Formulation,” Chemical Abstracts 107: 183629g pp. 498 (1987). |
Kitazawa et al., “Mitomycin and Trabeculectomy,” Arch Ophthalmol. 109:1693-1698 (1991). |
Kremer et al., “Adenovirus Vector-Transduced Hepatocytes Implanted via a Preformed Collagen/PTFE Support Persist for at Least 4 Weeks in vivo,” Gene Therapy 3:932-936 (1996). |
Marks et al., “Effects of Fibroblasts and Basic Fibroblast Growth Factor on Facilitation of Dermal Wound Healing by Type I Collagen Matrices,” J. Biomed. Mater. Res. 25:683-696 (1991). |
Martins et al., “The Controlled Release of Antibiotic by Hydroxyapatite: Anionic Collagen Composites,” Artif. Organs 22:215-221 (1998). |
Matsuoka et al., “Devlopment of an Interleukin-2 Slow Delivery System,” ASAIO Trans. 34:729-731 (1988). |
Matsuoka et al., “Immunotherapy by a Slow Delivery Stem of Interleukin-2 in Mice Models,” Acta Med Okayama 47:79-84 (1993). |
McPherson, “The Utility of Collagen-Based Vehicles in Delivery of Growth Factors for Hard and soft Tissue Wound Repair,” Clin. Mater. 9:225-234 (1992). |
Megevand et al., “The Effect of Reducing the Exposure Time of Mitomycin C in Glaucoma Filtering Surgery,” Ophthalmology 102:84-90 (1995). |
Mehta et al., “Gentamicin Distribution from a Collagen Carrier,” J. Orthop Res. 14:749-754 (1996). |
Meyskens et al., “A Phase I Trial of β-All-Trans-Retinoic Acid Delivered Via a Collagen Sponge and a Cervical Cap for Mild or Moderate Intraepithelial Cervical Neoplasia,” J. Natl. Cancer Inst. 71:921-925 (1983). |
Mietz et al., “Mitomycin C for Trabeculectomy in Complicated Glaucoma: Preliminary Results After 6 months,” Ger. J. Ophthalmol 3:164-167 (1994). |
Minabe et al., “Application of a Local Drug Delivery System in Periodontal Therapy: I. Development of Collagen Preparations With Immobilized Tetracycline,” J. Periodontal 60:113-117 (1989). |
M.S. El-Samaligy et al., “Reconstituted Collagen Nanoparticles, a Novel Drug Carrier Delivery System,” J. Pharm. Pharmacol. 35:537-539 (1983). |
Peng et al., “Cervical Tissue Uptake of All-Trans-Retinoic Acid Delivered Via a Collagen Sponge-Cervical Cap Delivery Device in Patients with Cervical Dysplasia,” Invest. New Drugs 4:245-249 (1986). |
Perka et al., “Experimental Studies of Mechanically-Induced Articular Cartilage Defects Following Implnatation of Allogeneic Embryonal Chondrocytes in a Collagen-Fibrin Gel in Chickens.” Z. Orthop. Ihre Grenzgeb. 134:562-572 (1996). |
Puelacher et al., “Tissue-Engineered Growth of Cartilage: The Effect of Varying the Concentration of Chrondrocytes Seeded Onto Synthetic Polymer Matrices,” Int. J. Oral. Maxillofac. Surg. 23:49-53 (1994). |
Punch et al., “The Release of Insoluble Antibiotics From Collagen Ocular Inserts In Vitro and Their Insertion into the Conjuctival Sac of Cattle,” J. Vet. Pharmacol. Ther. 10:37-42 (1987). |
Rao, “Recent Developments of Collagen-Based Materials for Medical Applications and Drug Delivery Systems,” J. Biomater Sci. Polym Ed. 7:623-645 (1995). |
Rao et al., “Implantable Controlled Delivery Systems for Proteins Based on Collagen-pHEMA Hydrogels,” Biomaterials 15:383-389 (1994). |
Rosenthal et al., “Collagen as Matrix for Neo-Organ Formation by Gene-Transfected Fibroblasts,” Anticancer Res. 17:1179-1186 (1997). |
Roy et al., “Extracellular Matrix Analogs as Carriers for Growth Factors; In Vitro Fibroblast Behavior,” Journal of Biomedical Materials Research 27:389-397 (1993). |
Rubin et al., “Collagen as a Vehicle for Drug Delivery,” The Journal of Clinical Pharmacology pp. 309-312 (1973). |
Rump et al., “Mitomycin-C Concentration in Human Ocular Aqueous Humor After Topical Administration During Trabeculectomy,” Arzneimittelforschung 45:1329-1330 (1995). |
Rutten et al., “Prevention of Wound Infection in Elective Colorectal Surgery by Local Application of a Gentamicin-Containing collagen Sponge,” Eur. J. Surg. Suppl. 578:31-35 (1997). |
Shelat et al., “Results of Intraoperative 5-Fluorouracil in Patients Undergoing Trabeculectomy—Pilot Trial,” Indian J. Ophthalmol 44:91-94 (1996). |
Sielaff et al., “Characterization of the Three-Compartment Gel-Entrapment Porcine Hepatocyte Bioartificial Liver,” Cell Biol. Toxicol. 13:367-364 (1997). |
Sutton et al., “Reduction of Vinblastine Neurotoxicity in Mice Utilizing a Collagen Matrix Carrier,” Sel. Cancer Ther. 6:35-49 (1990). |
Trafny et al., “Anti-Pseudomonal Activity of Collagen Sponge with Liposomal Polymyxin B,” Pharmacol Res. 33:63-65 (1996). |
Wachol-Drewek Z et al., “Comparative Investigation of Drug Delivery of Collagen Implants Saturated in Antibiotic Solutions and a Sponge Containing Gentamicin,” Biomaterials 17:1733-1738 (1996). |
Wakitani et al., “Repair of Large Full-Thickness Articular Cartilage Defects with Allograft Articular Chondrocytes Embedded in Collagen Gel,” Tissue Eng. 4:429-444 (1998). |
Wells et al., “Gel Matrix Vehicles for Growth Factor Application in Nerve Gap Injuries Repaired with Tubes: A Comparison of Biomatrix, Collagen, and Methylcellulose,” Experimental Neurology 146:395-402 (1997). |
Weiner et al., “Liposome-Collagen Gel Matrix: A Novel Sustained Drug Delivery,” J. Pharm. Sci. 74:922-925 (1985). |
Young et al., “Use of Mesenchymal Stem Cells in a Collagen Matrix for Achilles Tendon Repair,” J. Orthop. Res. 16:406-413 (1998). |
Chvapil, “Experimental Modifications of Collagen Synthesis and Degradation and Their Therapeutic Applications.” In Collagen in Health and Disease, Ch. 12, pp. 206-217, Eds. J.B. Weiss and M.I.V. Jayson, Churchill Lingingston, Edinburgh, 1982. |
Kitazawa et al., “Trabeculectomy With Mitomycin,” Arch. Ophthalmol. 269:1693-1698 (1991). |